Invivo Therapeutics' Chief Science Officer selected as recipient of 2011 Apple Award

NewsGuard 100/100 Score

InVivo Therapeutics (OTCBB: NVIV), a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that Chief Science Officer Dr. Christopher Pritchard, Ph.D., has been selected as the 2011 recipient of the American Spinal Injury Association's (ASIA) prestigious Apple Award. The award recognizes excellence in publishing in spinal cord injury research across the globe.

“Establishing a model spinal cord injury in the African green monkey for the preclinical evaluation of biodegradable polymer scaffolds seeded with human neural stem cells.”

Dr. Pritchard and his InVivo Therapeutics team authored the article titled: "Establishing a model spinal cord injury in the African green monkey for the preclinical evaluation of biodegradable polymer scaffolds seeded with human neural stem cells." The article was published in 2010 in the Journal of Neuroscience Methods (188, 258-269). Co-authors are Jonathan R. Slotkin, Dou Yu, Haining Dai, Matthew S. Lawrence, Roderick T. Bronson, Francis M. Reynolds, Yang D. Teng, Eric J. Woodard, and Robert S. Langer.

"This award recognizes one of several landmark studies supporting our technology and our brilliant team of scientists led by our Chief Medical Officer, Dr. Eric Woodard, and M.I.T.'s Dr. Robert S. Langer," said Frank Reynolds, CEO of InVivo Therapeutics. "Acknowledgement of this caliber is an honor and highlights the promise of our strategic initiatives. This study could not have been completed without the leadership from our Medical Director, Dr. Jonathan Slotkin, and our collaborator, Dr. Yang D. Teng, Director, Laboratories of Spinal Cord Injury and Neural Stem Cell Research at Harvard Medical School."

InVivo Therapeutics will receive The Apple Award from David F. Apple, Jr., M.D. on June 8, 2011, during the ASIA Annual Scientific Meeting in Washington, D.C. The award consists of a check for $2,000, a commissioned and engraved crystal apple sculpture, and the invitation to keynote the 2011 Research Day at Shepherd Center.

This is the fifth year that ASIA has presented The Apple Award, named in honor of Dr. Apple, founding member and past-president of ASIA. The award is a collaboration of three entities that have been critically important to Dr. Apple during his long career in orthopaedic surgery: Shepherd Center in Atlanta, Georgia, where he served as founding medical director for 30 years; the journal Topics in Spinal Cord Injury Rehabilitation, of which Dr. Apple is editor-in-chief; and ASIA.

Comments

  1. evaluator evaluator United States says:

    This article is ultra poor science. Look at the number of animals. How can anyone draw any conclusion whatsoever from n = 1 or n = 2. What in the world is going on?

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study finds patients with long COVID exhibit complement dysregulation with signs of thromboinflammation